Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04709861 · ClinicalTrials.gov registry record
TAR 2 Weeks vs 6 Weeks Post-Operative Weight-Bearing
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 33
- Enrollment target
NCT04709861: Clinical Trial study, sponsored by University of Oklahoma.
NCT04709861 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04709861 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The Investigators hypothesize that an early 2 week post-operative protocol will have no difference in the successful osseointegration and stability of the total ankle replacement as compared to a delayed 6 week post-operative protocol. The importance of the research is to allow patients who receive a total ankle replacement to bear weight 4 weeks earlier than the current protocol with no negative effect on the osseointegration and stability of the ankle replacement.
Primary Outcome
a Chi Square Test will take place during the post-operative care period and will be conducted as part of their post-operative care by the operating physician.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-04-07 |
| Est. Completion | 2024-03-16 |
Why NCT04709861 stopped before completion
NCT04709861 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04709861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04709861 about?
NCT04709861 is a clinical study titled "TAR 2 Weeks vs 6 Weeks Post-Operative Weight-Bearing". The Investigators hypothesize that an early 2 week post-operative protocol will have no difference in the successful osseointegration and stability of the total ankle replacement as compared to a delayed 6 week post-operative protocol. The importance of the research is to allow patients who receive ...
What is the current status of trial NCT04709861?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2021-04-07. Estimated completion is 2024-03-16.
Who is sponsoring clinical trial NCT04709861?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI